In 337 randomised recruitment calls for an Alzheimer's disease cohort (320 analysed), mentioning compensation lowered consent by 9.72 points vs control in intention-to-treat analysis (p=0.074, non-significant); the per-protocol difference was significant.
RCTn = 337 recruitment calls
Gabel et al. The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research